Skip to main content

Peer Review reports

From: The use of everolimus to target carcinogenic pathways in a patient with renal cell carcinoma and tuberous sclerosis complex: a case report

Original Submission
29 May 2013 Submitted Original manuscript
3 Jul 2013 Reviewed Reviewer Report - Joseph Pressey
22 Jul 2013 Author responded Author comments - Hye-Sook Kim
Resubmission - Version 2
22 Jul 2013 Submitted Manuscript version 2
29 Oct 2013 Author responded Author comments - Hye-Sook Kim
Resubmission - Version 3
29 Oct 2013 Submitted Manuscript version 3
Publishing
26 Dec 2013 Editorially accepted
10 Mar 2014 Article published 10.1186/1752-1947-8-95

You can find further information about peer review here.

Back to article page